MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹0.50 Cr | ₹0.65 Cr | ₹6.04 Cr | ₹7.84 Cr | ₹3.58 Cr |
What is the latest Total Non-Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2024 | ₹0.50 Cr |
| Mar2023 | ₹0.65 Cr |
| Mar2022 | ₹6.04 Cr |
| Mar2021 | ₹7.84 Cr |
| Mar2020 | ₹3.58 Cr |
How is Total Non-Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.50 Cr | -23.54 | |
| Mar2023 | ₹0.65 Cr | -89.23 | |
| Mar2022 | ₹6.04 Cr | -23.04 | |
| Mar2021 | ₹7.84 Cr | 118.92 | |
| Mar2020 | ₹3.58 Cr | - | |
Compare Total Non-Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹475.7 Cr | -1.7% | -13.5% | -8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,192.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,479.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
| CIPLA | ₹125,113.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹123,539.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,926.0 Cr | 2% | -1% | -7% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -1.7% |
-13.5% |
-8.8% |
| SENSEX | 1.3% |
-0.8% |
3.2% |
You may also like the below Video Courses